+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Bioactive Wound Dressing Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5176746
  • Report
  • August 2020
  • Region: Global
  • 120 Pages
  • Mordor Intelligence


  • 3M Company
  • B. Braun Melsungen AG
  • ConvaTec Group PLC
  • DermaRite Industries LLC
  • Hollister Incorporated
  • Johnson & Johnson
Bioactive wound care market is driven by advancements in technology, growing ageing population, the rising burden of chronic wounds and problems and associated with conventional wound healing procedures. Furthermore, increase in government initiatives, demand for fast and safe treatment for chronic wounds, increase in the prevalence of lifestyle disorders such as diabetes leading to venous leg ulcer, pressure ulcer and diabetic foot ulcer propels the growth of bioactive wound care market. According to the International Diabetes Federation 2019, approximately 463 million adults (20-79 years) were living with diabetes; by 2045 this will rise to 700 million. The proportion of people with type 2 diabetes is increasing in most countries. However, the high cost of treatment and unfavourable reimbursement policies are the few factors that hinder bioactive wound dressing market.

Key Market Trends

Alginate Dressing is Anticipated Have Significant Share

Alginate dressing refers to the natural wound dressings that are composed of highly absorbent materials and promote healing. These are widely used in exudnent wounds, where there is excess fluid.
  • Alginate dressing is usually made from seed wood thus, highly absorbent and provide a moist wound environment which is favourable in treating dry injuries.
  • Furthermorex`x, alginate dressing is suitable to treat bleeding wounds and keep nerve endings moist reducing pain. This makes them more preferable in treating heavily draining wounds, surgical wounds, first and second-degree burns, and in donor sites, this is likely to fuel the segment growth over the forecast period.

North America Expected to have Significant Market Share

North America bioactive wound dressing market is projected to have significant market share worldwide. Major factors that are driving the market in the region are rapidly growing ageing population, high number of diabetic population, and the developed healthcare system, which adapts to the novel innovations.​
  • The statistics show that around 30.3 million people in the United States were suffering from diabetes in 2017, and subsequently, the number is increasing. The International Diabetes Federation has stated that in the whole North American region, the number of people suffering from diabetes by the year 2045 may reach up to 62 million.​
  • Moreover, the presence of key market players such as 3M and others coupled with their activity in the launching of new products and R&D are expected to bolster the market growth in the region.
  • On the other hand, Europe bioactive wound dressing market is anticipated to have healthy growth rate owing to the adoption of new technologies, entry of market players and recent product launches. For inatnce, in Febrauary 2019 Norwegian company has received NOK 8 million to develop an industry-first bioactive gel-forming fibre dressing containing soluble beta-glucaninstanceinstance.

Competitive Landscape

Global bioactive wound dressing market is moderately fragmented and competitive. The key market players include 3M, Convatec, Mölnlycke Health Care, Smith and Nephew and B. Braun Melsungen AG among others

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown


  • 3M Company
  • B. Braun Melsungen AG
  • ConvaTec Group PLC
  • DermaRite Industries LLC
  • Hollister Incorporated
  • Johnson & Johnson

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic Wounds and Associated Diseases
4.2.2 Advancements in Bioactive Wound Dressings
4.3 Market Restraints
4.3.1 Lack of Proper Reimbursement
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Hydrocolloids
5.1.2 Alginate Dressing
5.1.3 Skin Substitutes
5.1.4 Antimicrobial Dressing
5.1.5 Other Products
5.2 By Application
5.2.1 Wounds
5.2.2 Burns
5.2.3 Ulcers
5.2.4 Other Applications
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-Eastst and Africa
5.3.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 3M Company
6.1.2 ConvaTec Group PLC
6.1.3 DermaRite Industries LLC
6.1.4 B. Braun Melsungen AG
6.1.5 Hollister Incorporated
6.1.6 Integra LifeSciences Holdings Corporation
6.1.7 Johnson & Johnson
6.1.8 Medtronic PLC
6.1.9 Mölnlycke Health Care AB
6.1.10 Smith & Nephew PLC
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 3M Company
  • ConvaTec Group PLC
  • DermaRite Industries LLC
  • B. Braun Melsungen AG
  • Hollister Incorporated
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Mölnlycke Health Care AB
  • Smith & Nephew PLC
Note: Product cover images may vary from those shown